We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

System Separates Circulating Tumor Cells from Blood Samples, Improves Cancer Diagnostics

By LabMedica International staff writers
Posted on 01 Jul 2022
Print article
Image: A new machine rapidly and robustly separates cancer cells from blood samples (Photo courtesy of DGIST)
Image: A new machine rapidly and robustly separates cancer cells from blood samples (Photo courtesy of DGIST)

Circulating tumor cells are cells that break off from cancers and are released into the blood stream. They can go on to form the seeds for new tumor formation in other parts of the body, known as metastases. The advantage of isolating them from the blood is that they represent the diversity of cancer cells found in a person’s body and identifying them could lead to more targeted therapies. But current techniques used to do this either miss some types of circulating tumor cells or are done manually, which takes a lot of time and specialized training. Now, a new approach can successfully and rapidly isolate rare circulating tumor cells from patient blood samples. The findings could help improve cancer diagnosis and the ability to provide targeted and personalized treatments.

The fully automated centrifugation approach developed by scientists at Daegu Gyeongbuk Institute of Science and Technology (DGIST, Daegu, Korea) and CTCELLS (Daegu, Korea) is called Continuous Centrifugal Microfluidics – Circulating Tumor Cell Disc (CCM-CTCD). It involves placing a tube containing a blood sample in a machine with a spinning disc. The spinning, or centrifugal force, causes the blood to separate into layers containing different components, with the heavier red blood cells dropping to the bottom, lighter cells floating in a middle layer, and plasma settling at the top.

After the disc begins to spin, a laser motor starts rotating at the same angular velocity and phase. This crucial step allows a laser to move and open a valve in the blood sample tube while the disc continues to spin, maintaining a thin layer of tumor and white blood cells, which are released into a separate chamber. The chamber contains antibodies that specifically attach to and separate white blood cells from the mixture. This allows the circulating tumor cells in the mixture to flow on their own into a final chamber.

The team went on to identify the different types of tumor cells and confirm by subsequent DNA testing that they represent the full diversity of different types of cells in the blood sample. They also used the technique on blood samples from patients with varying stages of lung cancer and found the number of circulating tumor cells in a sample correlated with the stage of disease progression. Identification of the types of tumor cells also allowed them to modify treatment strategies. The team is now working on commercializing the technique for clinical use and hopes to expand its application to isolate other types of cells, including nerve, stem and immune cells.

“Our smart and practical approach realizes a big dream in the field of liquid biopsy and demonstrates high performance across a wide range of cell types and different cancers with full automation,” said Minseok S. Kim at the Department of New Biology at DGIST.

Related Links:
DGIST 
CTCELLS 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.